Executives answered questions on the Wednesday earnings call about TAVR’s growth potential and results of a key clinical trial, released earlier this week, comparing the procedure to open-heart surgery.
Executives answered questions on the Wednesday earnings call about TAVR’s growth potential and results of a key clinical trial, released earlier this week, comparing the procedure to open-heart surgery.